SURAKSHA2024-07-012024-09-30 SURAKSHA2024-07-012024-09-30 SURAKSHA2024-07-012024-09-30in-bse-fin:OneOperatingExpenses01Member SURAKSHA2024-07-012024-09-30in-bse-fin:OneOperatingExpenses02Member SURAKSHA2024-07-012024-09-30in-bse-fin:OneOperatingExpenses03Member SURAKSHA2024-07-012024-09-30in-bse-fin:OneOperatingExpenses04Member SURAKSHA2024-07-012024-09-30in-bse-fin:OneOperatingExpenses05Member SURAKSHA2024-07-012024-09-30in-bse-fin:OneOperatingExpenses06Member SURAKSHA2024-07-012024-09-30in-bse-fin:OneOperatingExpenses07Member SURAKSHA2024-07-012024-09-30in-bse-fin:OneOperatingExpenses08Member SURAKSHA2024-07-012024-09-30in-bse-fin:OneOperatingExpenses09Member SURAKSHA2024-07-012024-09-30in-bse-fin:OneOperatingExpenses10Member SURAKSHA2024-07-012024-09-30in-bse-fin:FourOperatingExpenses01Member SURAKSHA2024-07-012024-09-30in-bse-fin:FourOperatingExpenses02Member SURAKSHA2024-07-012024-09-30in-bse-fin:FourOperatingExpenses03Member SURAKSHA2024-07-012024-09-30in-bse-fin:FourOperatingExpenses04Member SURAKSHA2024-07-012024-09-30in-bse-fin:FourOperatingExpenses05Member SURAKSHA2024-07-012024-09-30in-bse-fin:FourOperatingExpenses06Member SURAKSHA2024-07-012024-09-30in-bse-fin:FourOperatingExpenses07Member SURAKSHA2024-07-012024-09-30in-bse-fin:FourOperatingExpenses08Member SURAKSHA2024-07-012024-09-30in-bse-fin:FourOperatingExpenses09Member SURAKSHA2024-07-012024-09-30in-bse-fin:FourOperatingExpenses10Member SURAKSHA2024-09-30 iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 544293 SURAKSHA NA Suraksha Diagnostic Limited Equity 2024-04-01 2025-03-31 2024-12-20 2024-12-14 INR Lakhs Half yearly 11:45:00 18:20:00 2024-12-20 2024-12-20 true Cash Flow Indirect Not applicable Single segment DIAGNOSTIC 2024-07-01 2024-09-30 Unaudited Consolidated 667535000.00 13132000.00 680667000.00 79312000.00 0.00 0.00 110212000.00 21253000.00 87489000.00 246072000.00 544338000.00 136329000.00 0.00 136329000.00 35773000.00 -1000000.00 34773000.00 0.00 101556000.00 0.00 0.00 0.00 0.00 101556000.00 344000.00 101900000.00 103429000.00 -1873000.00 103773000.00 -1873000.00 86250000.00 2 1.94 1.94 0.00 0.00 1.94 1.94 1. The consolidated unaudited financial results for the quarter and half year ended September 30, 2024 ('the financial results ) of Suraksha Diagnostic Limited (Formerty known as Suraksha Diagnostic Private Limited) (The Company) and its subsidiaries (Holding Company and its subsidiaries together referred to as the group') have been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard (Ind AS) notified under Section 133 of the Companies Act, 2013, as amended, read with relevant rules thereunder and other accounting principies generally accepted in india and in accordance with Regulation 33 of the SEBI (Listing) Obligations and Disclosure Requirements) Regulations, 2015, as amended (the regulations ). 2. These financial results have been reviewed and recommended by the Audit Committee and approved by the Board of Directors in their respective meeting held on December 20, 2024. The statutory auditors have cared out limited review on these financial results and have issued an unmodified conclusion. 3. The figures for the corresponding quarter and half-year ended September 30, 2023 are presented based on the information complied by the management in accordance with ind AS and have not been subject to review or audit by the statutory auditors. However, the management has prepared the results for the said periods by applying consistent accounting policies. The requirement of submission of quarterly consolidated financial results is applicable on listing of equity shares of the Holding Company from the quarter ended September 30, 2024. Accordingly, these financial results have been prepared for the first time in compliance with the regulations. 4. Subsequent to the quarter and half-year ended September 30, 2024, the Holding Company has completed an Initial Public Offering entirely as offer for sale of 1,91,89,330 equity shares by existing share holders with face value of Rs.2 and listed on both National Stock exchange (NSE) and Bombay Stock Exchange (BSE) on December 06, 2024. 5. The Group is primarily engaged in the business of diagnostic centres for carrying out varous pathology and radiology services and as such there are no separate reportable segments as per Ind AS 108 - Operating Segments. 6. The figures for the quarter ended June 30, 2024 have been extracted from the audited special purpose ind AS interim Consolidated Financial Statements of the Group prepared for the purpose of inclusion in the offer documents. Further, the figures for the year ended March 31, 2024 have been extracted from the general purpose consolidated financial statements of the Group which were audited by the statutory auditors of the Group. 7. Subsequent to the quarter and half-year ended September 30, 2024, 0.0001% Compulsorily Convertible Preference Shares aggregating to 1,62,859 preference shares of par value Rs 100 each were converted into 89,55,761 equity shares of par value of Rs 2 each. 8. These financial results are also available on the Holding Company's website (www.surakshanet.com) and on the stock exchange websites (www.bseindia.com and www.nseinda.com). Single segment 2024-04-01 2024-09-30 Unaudited Consolidated 1274850000.00 24301000.00 1299151000.00 145679000.00 0.00 0.00 214003000.00 43405000.00 177417000.00 477186000.00 1057690000.00 241461000.00 0.00 241461000.00 66689000.00 -3452000.00 63237000.00 0.00 178224000.00 0.00 0.00 0.00 0.00 178224000.00 -2629000.00 175595000.00 182818000.00 -4594000.00 180189000.00 -4594000.00 86250000.00 2 3.43 3.43 0.00 0.00 3.43 3.43 Advertisement 8201000.00 Commission to collection centres 10720000.00 Information technology expenses 12984000.00 Other Expenses 31023000.00 Power and fuel 20122000.00 Professional fees paid to doctors 109025000.00 Rent Expense 8527000.00 Repairs and maintenance 21343000.00 Sample testing and collection charges 9164000.00 Security and housekeeping charges 14963000.00 Advertisement 18059000.00 Commission to collection centres 18748000.00 Information technology expenses 24054000.00 Other Expenses 60840000.00 Power and fuel 40934000.00 Professional fees paid to doctors 212513000.00 Rent Expense 16790000.00 Repairs and maintenance 39641000.00 Sample testing and collection charges 17558000.00 Security and housekeeping charges 28049000.00 -6218000.00 1385462000.00 47535000.00 0.00 0.00 722139000.00 4959000.00 0.00 0.00 0.00 0.00 0.00 122693000.00 122693000.00 0.00 46739000.00 2329527000.00 68540000.00 0.00 90183000.00 20267000.00 546493000.00 0.00 100755000.00 757698000.00 0.00 39876000.00 866114000.00 0.00 0.00 3195641000.00 86250000.00 1887966000.00 1974216000.00 1967998000.00 38681000.00 0.00 671166000.00 709847000.00 15121000.00 49523000.00 0.00 0.00 774491000.00 29690000.00 137449000.00 236270000.00 403409000.00 32926000.00 1320000.00 15497000.00 0.00 453152000.00 0.00 0.00 1227643000.00 3195641000.00 1. Instruments entirely equity in nature (CCPS) of Rs 162.86 Lacs has been added to other equity 43405000.00 -1757000.00 -7339000.00 0.00 -21142000.00 0.00 0.00 -94616000.00 0.00 -4180000.00 0.00 88024000.00 0.00 177417000.00 0.00 3227000.00 5215000.00 467000.00 0.00 0.00 0.00 18254000.00 0.00 0.00 0.00 0.00 3736000.00 0.00 0.00 174203000.00 415664000.00 0.00 0.00 0.00 42821000.00 0.00 372843000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1499000.00 199093000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 18054000.00 0.00 -72629000.00 0.00 -252169000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 17995000.00 0.00 103967000.00 0.00 4645000.00 0.00 1000000.00 -125607000.00 -4933000.00 0.00 -4933000.00 25200000.00 20267000.00 344000.00 -2629000.00 0.00 0.00 0.00 0.00